Office-Based Asthma Screening Intervention
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Asthma
- Sponsor
- University of Rochester
- Enrollment
- 365
- Locations
- 1
- Primary Endpoint
- "Preventive Medication Actions (PMA)" taken by the provider at the time of the child's visit. A "PMA" is defined as a new medication prescription or change in medication dose.
- Status
- Completed
- Last Updated
- 14 years ago
Overview
Brief Summary
In prior work, we found that even children who have been seen by their physicians within the prior six months were frequently misclassified as having mild rather than persistent asthma. This study evaluations whether systematic office-based screening assists primary care physicians in identifying children with significant asthma and improves preventive care for asthma. We hypothesize that standardized screening in the office setting will improve the physician's ability to (a) identify children with significant asthma and (b) prescribe appropriate preventive medications.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children ages 2-12
- •Children arriving for an office visit in two Rochester, NY pediatric clinics
- •Children with a prior diagnosis of asthma AND an exacerbation of symptoms within the previous 2 years
Exclusion Criteria
- •Children arriving at the office visit with an adult that is not their parent or guardian
- •Children arriving at the office visit with a parent or guardian that does not speak English
- •Children with other medical conditions making the assessment of asthma severity difficult (cystic fibrosis, heart conditions, etc.)
Outcomes
Primary Outcomes
"Preventive Medication Actions (PMA)" taken by the provider at the time of the child's visit. A "PMA" is defined as a new medication prescription or change in medication dose.
Secondary Outcomes
- Alternate actions taken by the provider such as: discussion of environmental controls, medication refills, etc.